We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Accelerated Pharma (MM) | NASDAQ:ACCP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
Accelerated Pharma, Inc.
36 Church Lane
Westport, Connecticut 06880
Application for Withdrawal of Registration Statement
August 23, 2017
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, D.C. 20549
Registration Statement on Form S-1
Filed on July 12, 2017
File No. 333-214048
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Act”), Accelerated Pharma, Inc.(the “Company”) hereby requests the withdrawal of the Company’s registration statement on Form S-1, the most recent amendment of which was filed with the United States Securities and Exchange Commission (the “SEC”) on July 12, 2017. The Company requests the withdrawal of the registration statement because the Company has decided not to proceed with this underwritten offering. The registration statement has not been declared effective and no shares of the Company’s common stock or other securities have been sold under the registration statement.
The Company requests that, in accordance with Rule 457(p) under the Act, all fees paid to the SEC in connection with the filing of the registration statement be credited for future use.
If you have any questions with respect to this matter, please call the Office of Richard Rubin, at 917-957-9092. Thank you for your assistance in this matter.
Respectfully submitted,
/s/: Michael Fonstein, PhD.
Michael Fonstein, CEO
1 Year ACCELERATED PHARMA, INC. Chart |
1 Month ACCELERATED PHARMA, INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions